Eptotermin alfa API Manufacturers
compare suppliers & get competitive offers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Eptotermin alfa API 129805-33-0?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Eptotermin alfa. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Eptotermin alfa
- Synonyms:
- BMP-7 , Bone morphogenetic protein 7 , Eptotermina alfa , HBMP7 , HrBMP-7 , Human recombinant bone morphogenetic protein 7 , OP-1 , Osteogenic protein 1 , RH-polypeptide-52
- Cas Number:
- 129805-33-0
- DrugBank number:
- DB11631
- Unique Ingredient Identifier:
- IT063R5MY0
General Description:
Eptotermin alfa, identified by CAS number 129805-33-0, is a notable compound with significant therapeutic applications. A bone morphogenetic protein that is widely expressed during EMBRYONIC DEVELOPMENT. It is both a potent osteogenic factor and a specific regulator of nephrogenesis. Eptotermin alfa is an ingredient in the EMA-withdrawn product Osigraft.
Classification:
Eptotermin alfa belongs to the None, classified under the direct parent group Peptides. This compound is a part of the Organic Compounds, falling under the Organic Acids superclass, and categorized within the Carboxylic Acids and Derivatives class, specifically within the Amino Acids, Peptides, and Analogues subclass.
Categories:
Eptotermin alfa is categorized under the following therapeutic classes: Amino Acids, Peptides, and Proteins, Biological Factors, Bone Morphogenetic Proteins, Drugs Affecting Bone Structure and Mineralization, Drugs for Treatment of Bone Diseases, Intercellular Signaling Peptides and Proteins, Musculo-Skeletal System, Peptides, Proteins, TGF-beta Superfamily Proteins. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
Eptotermin alfa is a type of Other substances
The pharmaceutical industry encompasses a diverse range of active pharmaceutical ingredients (APIs) that are used in the production of various medications. One category of APIs is known as other substances. This category includes substances that do not fall under the conventional classifications such as antibiotics, analgesics, or antihypertensives.
Other substances in pharmaceutical APIs consist of a broad array of chemical compounds with unique properties and applications. These substances play a crucial role in the formulation and development of specialized medications, catering to specific therapeutic needs. The category encompasses various substances like excipients, solvents, stabilizers, and pH adjusters.
Excipients are inert substances that aid in the manufacturing process and enhance the stability, bioavailability, and patient acceptability of pharmaceutical formulations. Solvents are used to dissolve other ingredients and facilitate their incorporation into the final product. Stabilizers ensure the integrity and shelf life of medications by preventing degradation or chemical changes. pH adjusters help maintain the desired pH level of a formulation, which can influence the drug's efficacy and stability.
Pharmaceutical manufacturers carefully select and incorporate specific other substances into their formulations, adhering to regulatory guidelines and quality standards. These substances undergo rigorous testing and evaluation to ensure their safety, efficacy, and compatibility with the desired pharmaceutical product. By employing other substances in API formulations, pharmaceutical companies can optimize drug delivery, improve patient compliance, and enhance therapeutic outcomes.
In summary, the other substances category of pharmaceutical APIs comprises a diverse range of chemicals, including excipients, solvents, stabilizers, and pH adjusters. These substances contribute to the formulation, stability, and performance of medications, enabling pharmaceutical manufacturers to develop specialized products that meet specific therapeutic requirements.
